PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Sean McCarthy will participate on a panel at the BIO International Convention in San Diego, CA titled "New Models for External Innovation by Pharma"
News | 06. 17. 2008
